REISTONE BIOPHARMA
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90701059
- Registration number
- 6728699
- Mark type
- Stylized text
- Filed
- 10 May 2021
- Published for opposition
- 01 Mar 2022
- Registered
- 24 May 2022
- Attorney of record
- Jessica R. Manganello
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines; Research and development of vaccines and medicines; Research in the field of pharmaceuticals; Biochemical research and development
Owner
- Reistone Biopharma, Inc., Rosemont, IL, US
- Reistone Biopharma, Inc., Boston, MA, US
- Reistone Biopharma, Inc., Boston, MA, US
Prosecution history
- 18 Jul 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jul 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Mar 2022 — PUBLISHED FOR OPPOSITION
- 09 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jan 2022 — ASSIGNED TO EXAMINER
- 10 Aug 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 May 2021 — NEW APPLICATION ENTERED